Archives

by in
Entry Author Date Location
Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer Cells 04/15/10 Boston
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes 04/14/10 Boston
Third Rock Eying $400M Second Fund 04/14/10 Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy 03/12/10 Boston
Former CombinatoRx CEO Alexis Borisy Lands at Third Rock Ventures, Launches New Startup 02/11/10 Boston
Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News 12/23/09 Boston
Agios, Seeking to Starve Cancer Cells to Death, Wins Support from Brain Tumor Foundation 12/21/09 Boston
New VC in Boston: Arch Venture Partners Opens Small Office With Eye Toward Basic Science, Multidisciplinary Collaborations 09/21/09 Boston
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News 05/28/09 Boston
Agios Lands Genentech Cancer Drug Leader as New CEO 05/27/09 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News 11/26/08 Boston
Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells 11/24/08 Boston
Third Rock Ventures Heads “Back to the Basics,” Nurtures Disruptive Life Sciences Companies 09/23/08 Boston
GT Solar Sees Brighter IPO Skies; Pfizer, Merck, and Eli Lilly Back Boston Startup; GSI Group Beams out $360M for Excel Technology & More Deals News 07/14/08 Boston
Agios Pharmaceuticals Lands $33,000,000 Series A Financing 07/07/08 Boston
Page 3 of 3 « previous page